RAREUltragenyx Pharmaceutical Inc
RARE
Ultragenyx Pharmaceutical Inc2,852
Mkt Cap
$2.26BVolume
1.67M52W High
$43.2252W Low
$18.41PE Ratio
-4.01RARE Fundamentals
Price
$23.02Prev Close
$23.39Open
$22.5450D MA
$24.96Beta
1.06Avg. Volume
2.87MEPS (Annual)
-$5.83P/B
-28.18Rev/Employee
$490,882.57$2,833.80
Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit Seeks Recovery for Investors; April 6, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit Seeks Recovery for Investors; April 6, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP Ultragenyx Pharmaceutical Inc. (RARE...
PR Newswire·10h ago
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc...
PR Newswire·16h ago
Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE
Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact...
PR Newswire·16h ago
Vanguard Group Inc. Sells 80,694 Shares of Ultragenyx Pharmaceutical Inc. $RARE
Vanguard Group Inc. trimmed its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) by 0.8% in the third quarter, according to its most recent filing with the SEC. The...
MarketBeat·2d ago
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Ultragenyx...
PR Newswire·3d ago
RARE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
RARE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 RARE SHAREHOLDER ACTION REMINDER: Faruqi...
PR Newswire·3d ago
Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RARE
Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RARE Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity...
PR Newswire·4d ago
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit PR...
PR Newswire·4d ago
LEVI & KORSINSKY, LLP: MANAGEMENT CONFIDENCE REPRESENTATIONS CHALLENGED IN ULTRAGENYX PHARMACEUTICAL SECURITIES ACTION
LEVI & KORSINSKY, LLP: MANAGEMENT CONFIDENCE REPRESENTATIONS CHALLENGED IN ULTRAGENYX PHARMACEUTICAL SECURITIES ACTION LEVI & KORSINSKY, LLP: MANAGEMENT CONFIDENCE REPRESENTATIONS CHALLENGED IN...
PR Newswire·5d ago
Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline
Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline...
PR Newswire·6d ago
<
1
2
...
>